HBEGF and necrotizing enterocolitis: Heparin-binding epidermal growth factor (EGF)-like growth factor (HB-EGF), which was first identified in the conditioned medium of macrophage-like cells, can protect ISCs from in vitro hypoxic injury and in vivo NEC model [14].